Eddie Joe Sullivan - 07 Dec 2023 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Chief Executive Officer, Director
Signature
/s/ Eddie Joe Sullivan
Issuer symbol
SABS
Transactions as of
07 Dec 2023
Net transactions value
+$1,531
Form type
4
Filing time
08 Dec 2023, 08:00:05 UTC
Previous filing
16 Mar 2023
Next filing
23 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Purchase $1,531 +1,740 +0.03% $0.8800 5,232,304 07 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 1,740 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.